-
Single cell RNA sequencing of CD19 CAR T-cell infusion products
Study
EGAS00001004576
-
Pediatric Low-Grade Glioma RNA and Targeted Sequencing
Study
EGAS00001004242
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
Mutation signatures in melanocytic nevi reveal characteristics of defective DNA repair
Study
EGAS00001004274
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Neuroblastoma Cell Line Circle-seq
Study
EGAS00001004796
-
Successful BRAF/MEK-inhibition in a young patient with BRAF V600E-mutated extrapancreatic acinar cell carcinoma (HIPO-021)
Study
EGAS00001004282
-
Cross-species genomics identifies TAF12, NFYC and RAD54L as novel choroid plexus carcinoma oncogenes
Study
EGAS00001000961
-
The Genomic Landscape of Childhood and Adolescent Melanoma
Study
EGAS00001000901
-
Genomic_landscape_of_liver_cirrhosis
Study
EGAS00001004329
-
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Study
EGAS00001000906
-
Dissecting intratumor heterogeneity of nodal B cell lymphoma on the transcriptional, genetic, and drug response level
Study
EGAS00001004335
-
Persistent STAG2 mutation in recurrent pediatric glioblastoma
Study
EGAS00001004340
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Study
EGAS00001004349
-
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Study
EGAS00001001024
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Genetic_profiling_of_mucosal_melanoma
Study
EGAS00001001115
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
Leeds_Melanoma_Cohort
Study
EGAS00001001158
-
Predicting brain tumor recurrence: development and validation of a DNA-methylation based nomogram in meningioma
Study
EGAS00001003490
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Study
EGAS00001003493
-
Pre-neoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Dataset
EGAD00001011097
-
Human melanoma samples with and without resistance to BRAF inhibitor therapy
Study
EGAS00001000992
-
ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000561
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
Study
EGAS00001001199
-
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Study
EGAS00001001002
-
Spatial heterogeneity in medulloblastoma
Study
EGAS00001001014
-
Exome and transcriptome sequencing of Desmoplastic Small Round Cell Sarcoma
Study
EGAS00001004575
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Exploration of CNV’s and SNV’s in cancers with well-known genetic rearrangements: Identification of additional genetic changes in rearrangements-driven cancer
Study
EGAS00001000673
-
Blueprint RNAseq profile of purified plasma cells from multiple myeloma patients and tonsils of healthy donors
Study
EGAS00001001110
-
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Study
EGAS00001001190
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
The genomic landscape of primary cutaneous anaplastic large cell lymphoma (pcALCL)
Study
EGAS00001004429
-
Neuroblastoma relapse trio series from the AMC
Study
EGAS00001001183
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
Comprehensive Transcriptional Analysis of Early Stage Urothelial Carcinoma using whole transcriptome sequencing
Study
EGAS00001001236
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Targets of MEK inhibition in DIPG
Study
EGAS00001004495
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
Study
EGAS00001004499
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Study
EGAS00001001184
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Deciphering the mutational landscape and the genome organization of LMS
Study
EGAS00001001262
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723